Assembly Biosciences ASMB
NASDAQ ASMB
$23.52 +0.04 (+0.17%)
As of: Sep 30, 2026 · 3:59 PM EDT

Assembly Biosciences (ASMB) Total Non-Current Liabilities (2014 - 2019)

Updated

Assembly Biosciences (ASMB) recorded Total Non-Current Liabilities of $66.69 million in Q4 2019, up 71.4% from $38.92 million a year earlier but down 0.2% from the prior quarter.

Analysis

Assembly Biosciences (ASMB) Total Non-Current Liabilities (2014 - 2019) Analysis & Trends

Starting with Q4 2014, Assembly Biosciences' Total Non-Current Liabilities history includes 20 quarters.

  • Annual Total Non-Current Liabilities has a five-year compound annual growth rate of 41.9% (FY2014 to FY2019).
  • Across earlier years, Total Non-Current Liabilities came in at $38.92 million in FY2018 (-8.8%), $42.69 million in FY2017 (+283.9%), $11.12 million in FY2016 (-4.1%) and $11.6 million in FY2015 (unchanged).
  • Quarterly Total Non-Current Liabilities has ranged from $11.12 million in Q4 2016 to $68.85 million in Q1 2019 over the past five years.
  • On a year-over-year basis, Total Non-Current Liabilities has increased for four consecutive quarters, with growth averaging 23.6% over the last eight quarters.
  • Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 377.9% in Q1 2017, against a decline of 26.5% in Q3 2018 at the low end.
  • Per Business Quant, the preceding three quarters came in at $66.86 million (Q3 2019), $66.8 million (Q2 2019) and $68.85 million (Q1 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 105.99 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 106.45 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -967.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 5.92 Bn
10 Assembly Biosciences 466.09 Mn -561.54 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 66.69 Mn
Sep 30, 2019 66.86 Mn
Jun 30, 2019 66.80 Mn
Mar 31, 2019 68.85 Mn
Dec 31, 2018 38.92 Mn
Sep 30, 2018 38.93 Mn
Jun 30, 2018 40.19 Mn
Mar 31, 2018 41.46 Mn
Dec 31, 2017 42.69 Mn
Sep 30, 2017 52.96 Mn
Jun 30, 2017 54.25 Mn
Mar 31, 2017 55.44 Mn
Dec 31, 2016 11.12 Mn
Sep 30, 2016 11.60 Mn
Jun 30, 2016 11.60 Mn
Mar 31, 2016 11.60 Mn
Dec 31, 2015 11.60 Mn
Sep 30, 2015 11.60 Mn
Jun 30, 2015 11.60 Mn
Dec 31, 2014 11.60 Mn
API Access

Assembly Biosciences Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ASMB&period=max&api_key=YOUR_API_KEY